EUVIMED · CrossrefZeitschrift
Medicine in Drug Discovery
ISSN 2590-0986 · Elsevier BV
Neueste Artikel
From mushroom metabolome to prioritized anti-diabetic metabolite candidates: LC-MS/MS and AIDDISON™-assisted screening of Pleurotus citrinopileatus
GPCR-PTM: an interpretable, topology-aware rule-based framework for residue-level post-translational modification annotation and prediction across the human GPCRome
Microbiota-derived metabolites in cancer: Dual roles in pathogenesis and opportunities for therapy
From ferments to fixers: Postbiotics in wound healing
Revolutionizing pharmacology: AI-powered approaches in molecular modeling and ADMET prediction
Combating bacterial antibiotic resistance with phytocompounds: Current trends and future perspectives
NeBULA: a web-based novel drug design platform for up-to-date bioisosteric replacement
Repurposing oncology drugs for Alzheimer’s: multi-omic convergence targeting cell-cycle, proteostasis, immunometabolism, and senescence
Antioxidant and biocompatible CuO-starch/PVA nanoscaffolds via ultrasonic green synthesis using Turbinaria conoides (brown marine macroalgae)
Novel indole-based synthetic molecules in cancer treatment: Synthetic strategies and structure-activity relationship
Current demands for standardization of Indian medicinal plants: A critical review
Generative AI for drug discovery and protein design: the next frontier in AI-driven molecular science
Repositioning of rhodanine-thiazole hybrids as aldose reductase inhibitors
Leveraging network pharmacology for drug discovery: Integrative approaches and emerging insights
Design and development of PROTACs: A new paradigm in anticancer drug discovery
Bacterial-based drug delivery systems: A new way to combat infectious disease
Understanding drug resistance in breast cancer: Mechanisms and emerging therapeutic strategies
Recent approaches in nanotoxicity assessment for drug delivery applications: Challenges and prospects
Recent developments in receptor tyrosine kinase inhibitors: A promising mainstay in targeted cancer therapy
A complex molecular landscape to drug delivery concept for achieving precise therapy in psoriasis
In vitro human colon microbiota culture model for drug research
Albumin is a reliable drug-delivering molecule: Highlighting points in cancer therapy
Crocin supplementation in primary open angle glaucoma: A randomized, triple-blind, placebo-controlled clinical trial
Biomarkers navigate drug development: Pharmacology, effectiveness and safety
Therapeutic potential of snake venom: Toxin distribution and opportunities in deep learning for novel drug discovery
Microemulsions for enhancing drug delivery of hydrophilic drugs: Exploring various routes of administration
Lipid polymer hybrid nanoparticles as potent vehicles for drug delivery in cancer therapeutics
Antisense oligonucleotide based therapeutics and its applications against bacterial infections
Fluid mechanics in circulating tumour cells: Role in metastasis and treatment strategies
Repurposing of drugs for combined treatment of COVID-19 cytokine storm using machine learning
EUVIMED